Doctor profile · Federal record
Dr. Mark Pascal, MD
Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology (Internal Medicine) Physician · Hackensack, NJ
- NPI 1700847373
- Accepts Medicare
- MIPS 79.9 / 100 · 2023
- 53 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
92 2Nd St
Hackensack, NJ 076012191
(551) 996-4202
fax (551) 996-0598 - Additional location
-
795 Franklin Ave
Franklin Lakes, NJ 074171368
(201) 848-8791
fax (201) 848-9604
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- January 26, 2022
- Year of graduation
- 1973 — 53 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- New Jersey #25MA03545200
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1700847373. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
17,249
Distinct HCPCS
7
Medicare allowed
$363,532
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 15,200 | 33 | $7 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,013 | 253 | $140 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 352 | 148 | $99 | |
96372 |
Injection of drug or substance under skin or into muscle | 317 | 37 | $16 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 295 | 171 | $194 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 59 | 59 | $174 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 13 | 11 | $85 |
In context: peer comparison
Among 12 peers in Hackensack Medical Oncology Physician, average services per provider: 1,060. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$1,907
Transactions
66
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $459.58 | |
| Merck Sharp & Dohme LLC | 14 | $228.19 | |
| Alexion Pharmaceuticals, INC. | 4 | $175.21 | |
| Incyte Corporation | 3 | $132.51 | |
| Apellis Pharmaceuticals, INC. | 5 | $93.65 | |
| E.R. Squibb & Sons, L.L.C. | 6 | $88.87 | |
| AstraZeneca Pharmaceuticals Lp | 4 | $77.34 | |
| Agios Pharmaceuticals, INC. | 4 | $72.96 | |
| Regeneron Healthcare Solutions, INC. | 4 | $71.24 | |
| Daiichi Sankyo INC. | 4 | $67.01 | |
| Pharmacosmos Therapeutics INC. | 3 | $53.91 | |
| Rigel Pharmaceuticals, INC. | 3 | $52.77 | |
| Takeda Pharmaceuticals U.S.A., INC. | 2 | $36.97 | |
| Emd Serono, INC. | 2 | $32.24 | |
| Pfizer INC. | 2 | $31.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
148
Patients
26
Total drug cost
$376,867
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 58 | 26 | $2,646 |
| Anagrelide Hcl | Generic | 17 | 0 | $4,142 |
| Abiraterone Acetate | Generic | 15 | 0 | $15,163 |
| Eliquis (Apixaban) | Brand | 12 | 0 | $9,931 |
| Warfarin Sodium | Generic | 12 | 0 | $211 |
| Xarelto (Rivaroxaban) | Brand | 12 | 0 | $7,078 |
| Erleada (Apalutamide) | Brand | 11 | 0 | $162,835 |
| Imbruvica (Ibrutinib) | Brand | 11 | 0 | $174,862 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Pascal's medical specialty?
Dr. Mark Pascal practices Medical Oncology Physician in Hackensack, NJ.
Where does Dr. Mark Pascal practice?
Dr. Mark Pascal practices at 92 2Nd St, Hackensack, NJ 076012191. Office phone: 5519964202.
What is Dr. Mark Pascal's NPI?
Dr. Mark Pascal's National Provider Identifier (NPI) is 1700847373, issued by NPPES.
Does Dr. Mark Pascal accept Medicare assignment?
Yes. Dr. Mark Pascal accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Pascal commonly perform?
Top Medicare-reported procedures in 2023: Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS J0885); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.